Robert Califf’s controversial opinions on advisory committee votes have a lawmaker’s attention, potentially further pressuring the direction of reform efforts.
Key Takeways
-
Califf said no one is advocating for scrapping adcomm votes completely.
-
If the FDA always agreed there would be no need for the agency, Califf said in response to criticism about discordance with adcomm recommendations
Sen
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?